BACKGROUND: Mutations of presenilin 2 gene are a rare cause of familial Alzheimer disease (AD). We describe an Italian family with hereditary dementia associated with a novel mutation in the presenilin 2 gene. METHODS: Clinical investigations of the diseased subjects; interviews with relatives; studies of medical records; pedigree analysis; and neuroradiologic, neuropathologic, and molecular genetic studies were carried out in the pedigree. RESULTS: Genetic analysis showed a novel PSEN2 A85V mutation present in the proband and in all analyzed affected members, in a subject presenting with an amnesic mild cognitive impairment, and in a young, still asymptomatic subject. The proband showed a clinical phenotype indicative of Lewy body dementia and the neuropathologic examination demonstrated the presence of unusually abundant and widespread cortical Lewy bodies in addition to the hallmark lesions of AD. Other affected members exhibited a clinical phenotype typical of AD. CONCLUSIONS: Our findings add complexity to the spectrum of atypical phenotypes associated with presenilin mutations and should then be taken into account when considering the nosography of neurodegenerative diseases. They also support previous data that specific mutations of genes associated with familial Alzheimer disease may influence the presence and extent of Lewy bodies.
BACKGROUND: Mutations of presenilin 2 gene are a rare cause of familial Alzheimer disease (AD). We describe an Italian family with hereditary dementia associated with a novel mutation in the presenilin 2 gene. METHODS: Clinical investigations of the diseased subjects; interviews with relatives; studies of medical records; pedigree analysis; and neuroradiologic, neuropathologic, and molecular genetic studies were carried out in the pedigree. RESULTS: Genetic analysis showed a novel PSEN2A85V mutation present in the proband and in all analyzed affected members, in a subject presenting with an amnesic mild cognitive impairment, and in a young, still asymptomatic subject. The proband showed a clinical phenotype indicative of Lewy body dementia and the neuropathologic examination demonstrated the presence of unusually abundant and widespread cortical Lewy bodies in addition to the hallmark lesions of AD. Other affected members exhibited a clinical phenotype typical of AD. CONCLUSIONS: Our findings add complexity to the spectrum of atypical phenotypes associated with presenilin mutations and should then be taken into account when considering the nosography of neurodegenerative diseases. They also support previous data that specific mutations of genes associated with familial Alzheimer disease may influence the presence and extent of Lewy bodies.
Authors: Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird Journal: Brain Date: 2010-04 Impact factor: 13.501
Authors: Terhi Peuralinna; Liisa Myllykangas; Minna Oinas; Mike A Nalls; Hannah A D Keage; Veli-Matti Isoviita; Miko Valori; Tuomo Polvikoski; Anders Paetau; Raimo Sulkava; Paul G Ince; Julia Zaccai; Carol Brayne; Bryan J Traynor; John Hardy; Andrew B Singleton; Pentti J Tienari Journal: Ann Clin Transl Neurol Date: 2015-08-18 Impact factor: 4.511
Authors: Mario Masellis; Kayla Sherborn; Pedro Neto; Dessa A Sadovnick; Ging-Yuek R Hsiung; Sandra E Black; Sadhana Prasad; Meghan Williams; Serge Gauthier Journal: Alzheimers Res Ther Date: 2013-07-31 Impact factor: 6.982
Authors: Rachael I Scahill; Gerard R Ridgway; Jonathan W Bartlett; Josephine Barnes; Natalie S Ryan; Simon Mead; Jonathan Beck; Matthew J Clarkson; Sebastian J Crutch; Jonathan M Schott; Sebastien Ourselin; Jason D Warren; John Hardy; Martin N Rossor; Nick C Fox Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472